4.7 Article

Suppression of E-Cadherin Function Drives the Early Stages of Ras-Induced Squamous Cell Carcinoma through Upregulation of FAK and Src

期刊

JOURNAL OF INVESTIGATIVE DERMATOLOGY
卷 131, 期 11, 页码 2306-2315

出版社

ELSEVIER SCIENCE INC
DOI: 10.1038/jid.2011.188

关键词

-

资金

  1. NIDCR [2RO1DE011250-06, DE017413]
  2. NIGMS [GM47717]

向作者/读者索取更多资源

Advanced stages of epithelial carcinogenesis involve the loss of intercellular adhesion, but it remains unclear how proteins that regulate alterations in cell-cell and cell-matrix adhesion are deregulated to promote the early stages of cancer development. To address this, a three-dimensional human tissue model that mimics the incipient stages of squamous cell carcinoma (SCC) was used to study how E-cadherin suppression promotes tumor progression in Ras-expressing human keratinocytes. We found that E-cadherin suppression triggered elevated mRNA and protein expression levels of focal adhesion kinase (FAK), and increased FAK and Src activities above the level seen in Ras-expressing E-cadherin-competent keratinocytes. The short hairpin RNA (shRNA)-mediated depletion of FAK and Src restored E-cadherin expression levels by increasing its stability in the membrane, and blocked tumor cell invasion in tissues. Surface transplantation of these tissues to mice resulted in reversion of the tumor phenotype to low-grade tumor islands in contrast to control tissues that manifested an aggressive, high-grade SCC. These findings suggest that the tumor-promoting effect of E-cadherin suppression, a common event in SCC development, is exacerbated by enhanced E-cadherin degradation induced by elevated FAK and Src activities. Furthermore, they imply that targeting FAK or Src in human epithelial cells with neoplastic potential may inhibit the early stages of SCC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer

Fen Ma, Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben, Zhongkai Gu, Joshua W. Russo, David J. Einstein, Huihui Ye, Meng Xiao He, Yu Liu, Eliezer Van Allen, Adam G. Sowalsky, Manoj K. Bhasin, Xin Yuan, Steven P. Balk

Summary: This study reveals the importance of Wnt/beta-catenin signaling in prostate cancer, showing its role in stem cell maintenance and invasion. It identifies new effectors and drivers of this pathway in prostate cancer, such as ROR1 and APC genomic loss. The findings suggest that targeting Wnt/beta-catenin signaling may be a potential therapeutic strategy for prostate cancer.

CANCER RESEARCH (2022)

Article Oncology

Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications

Xin Dong, Hui Xue, Fan Mo, Yen-Yi Lin, Dong Lin, Nelson K. Y. Wong, Yingqiang Sun, Scott Wilkinson, Anson T. Ku, Jun Hao, Xinpei Ci, Rebecca Wu, Anne Haegert, Rebecca Silver, Mary-Ellen Taplin, Steven P. Balk, Joshi J. Alumkal, Adam G. Sowalsky, Martin Gleave, Colin Collins, Yuzhuo Wang

Summary: This study aimed to develop clinically relevant models for studying ADT-induced prostate cancer dormancy. The researchers established 11 ADT-induced dormant prostate cancer models that closely mimicked the clinical courses of ADT-treated prostate cancer and identified two ADT-induced dormancy subtypes that differed in morphology, gene expression, and relapse rates. They also discovered transcriptomic differences in precastration PDXs that predisposed the dormancy response to ADT and developed a dormancy subtype-based, predisposed gene signature that was significantly associated with ADT response in hormonal naive prostate cancer and clinical outcome in castration-resistant prostate cancer treated with ADT or androgen-receptor pathway inhibitors.

MOLECULAR CANCER RESEARCH (2022)

Article Urology & Nephrology

Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer

John R. Bright, Rosina T. Lis, Anson T. Ku, Nicholas T. Terrigino, Nichelle C. Whitlock, Shana Y. Trostel, Nicole Carrabba, Stephanie A. Harmon, Baris Turkbey, Scott Wilkinson, Adam G. Sowalsky

Summary: The study evaluated the ability of antibodies against PSMA to specifically detect residual tumor in patients treated with iADT and enzalutamide. The results showed that PSMA reacted positively with tumor in all cases and had high sensitivity but low specificity for benign regions. PSMA could also identify highly dedifferentiated prostate carcinomas, indicating its potential as a valuable marker.

JOURNAL OF UROLOGY (2022)

Article Oncology

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

Adam G. Sowalsky, Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan, Wei Yuan, Joshua W. Russo, John R. Bright, Nichelle C. Whitlock, Shana Y. Trostel, Anson T. Ku, Radhika A. Patel, Lawrence D. True, Jonathan Welti, Juan M. Jimenez-Vacas, Daniel Nava Rodrigues, Ruth Riisnaes, Antje Neeb, Cynthia T. Sprenger, Amanda Swain, Scott Wilkinson, Fatima Karzai, William L. Dahut, Steven P. Balk, Eva Corey, Peter S. Nelson, Michael C. Haffner, Stephen R. Plymate, Johann S. de Bono, Adam Sharp

Summary: This study demonstrates that further analytical validation and clinical qualification are required before AR-V7 can be considered for clinical use in CSPC as a predictive biomarker.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood

Jennifer Wilkinson Carlisle, Caroline S. Jansen, Maria Andrea Cardenas, Ewelina Sobierajska, Adriana Moon Reyes, Rachel Greenwald, Luke Del Balzo, Nataliya Prokhnevska, Omer Kucuk, Bradley C. Carthon, Patrick Connor Mullane, Adeboye Osunkoya, Deborah Baumgarten, Fares Hosseinzadeh, Scott Wilkinson, Ross Lake, Adam G. Sowalsky, Yuan Liu, Viraj A. Master, Mehmet A. Bilen, Haydn Kissick

Summary: This study identifies potential immunological biomarkers that can predict therapeutic response in patients with advanced renal cell carcinoma (RCC). Assessing changes in T cells in the peripheral blood and tumor microenvironment, the researchers found that patients with the highest increase in specific activated T cells had the best antitumor immune response and clinical benefit.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Editorial Material Oncology

Unpacking circulating tumor DNA lends insight into prostate cancer biology and the clonal dynamics of metastasis

David Y. Takeda, Adam G. Sowalsky

Summary: A recent report in Nature demonstrates that whole-genome sequencing of circulating tumor DNA from patients with metastatic PCa can inform on the subclonal composition of metastatic disease and infer patterns of gene expression.

CANCER CELL (2022)

Article Biology

Defining cellular population dynamics at single-cell resolution during prostate cancer progression

Alexandre A. Germanos, Sonali Arora, Ye Zheng, Erica T. Goddard, Ilsa M. Coleman, Anson T. Ku, Scott Wilkinson, Hanbing Song, Nicholas J. Brady, Robert A. Amezquita, Michael Zager, Annalysa Long, Yu Chi Yang, Jason H. Bielas, Raphael Gottardo, David S. Rickman, Franklin W. Huang, Cyrus M. Ghajar, Peter S. Nelson, Adam G. Sowalsky, Manu Setty, Andrew C. Hsieh

Summary: In this study, we found that the expansion of castration-resistant intermediate luminal cells is associated with treatment resistance and poor prognosis in prostate cancer. The transformed epithelial cells and associated fibroblasts create a microenvironment that promotes pro-tumorigenic immune infiltration, which is influenced by androgen levels. Androgen-independent prostate cancer leads to significant diversification of intermediate luminal cell populations with varying androgen signaling activities, which are inversely correlated with proliferation and mRNA translation. The findings suggest that targeting translation inhibition could potentially lead to epithelial cell death, loss of pro-tumorigenic signaling, and decreased tumor heterogeneity.
Editorial Material Oncology

Defining biology and recurrence risk in prostate cancers treated by neoadjuvant chemohormonal therapy

Scott Wilkinson, Adam G. Sowalsky

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Meeting Abstract Oncology

STEM-LIKE CD8 T-CELLS RESIDING IN ANTIGEN PRESENTING IMMUNE NICHES ARE PROGNOSTIC FOR LOCAL CONTROL IN BRAIN METASTASES AND ARE SUSTAINED FOLLOWING RADIATION THERAPY

Caroline Jansen, Prasanthi Chappa, Nataliya Prokhnevska, Maria Cardenas, Roshan Prabhu, Jim Zhong, Kimberly Hoang, Subir Goyal, Suzanna Logan, Jeffrey Olson, Edjah Nduom, Luke del Balzo, Kirtesh Patel, Stuart Burri, Anthony Asher, Scott Wilkinson, Ross Lake, Kristin Higgins, Pretesh Patel, Vishal Dhere, Mylin Torres, Adam Sowalsky, Mohammad Khan, Haydn Kissick, Zachary Buchwald

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Oncology

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

Nichelle C. Whitlock, Margaret E. White, Brian J. Capaldo, Anson T. Ku, Supreet Agarwal, Lei Fang, Scott Wilkinson, Shana Y. Trostel, Zhen-Dan Shi, Falguni Basuli, Karen Wong, Elaine M. Jagoda, Kathleen Kelly, Peter L. Choyke, Adam G. Sowalsky

Summary: Our study reveals that the epigenetic activity of transcription factor oncogenes undergoes a shift during prostate cancer progression, leading to distinctive effects on metabolism. These epigenetically-driven changes in lipid metabolism may serve as novel targets for the development of imaging agents and therapeutics.

DISCOVER ONCOLOGY (2022)

Meeting Abstract Oncology

Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer.

Rahim Hirani, Subhiksha Nandakumar, Teja Kalidindi, Deborah Fidele, Harisha Rajanala, Ying Mazzu, Yuki Yoshikawa, Lina Jehane, Gwo-Shu Mary Lee, Elisa de Stanchina, Adam Sowalsky, Michael J. Morris, Heiko Schoder, Naga Vara Kishore Pillarsetty, Lorelei A. Mucci, Daniel Danila, Goutam Chakraborty, Philip W. Kantoff

CANCER RESEARCH (2021)

Meeting Abstract Oncology

An immunologic niche of antigen presenting cells and stem-like CD8+T-cells is present in non-small cell lung cancer brain metastases.

Caroline S. Jansen, Luke del Balzo, Roshan Prabhu, Suzanna Logan, Prasanthi Chappa, Kirtesh Patel, Scott Wilkinson, Ross Lake, Hui-Kuo G. Shu, Jim Zhong, Vishal Dhere, Jeffrey Olson, Adam G. Sowalsky, Mohammad K. Khan, Haydn T. Kissick, Zachary S. Buchwald

CLINICAL CANCER RESEARCH (2021)

暂无数据